SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancers-Reference-Cited by-同舟云学术

SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancers

Published:2021-01 Issue:10 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Zhang Qun¹,Cheng Lei²,Qin Yanmei³,Kong Linghui¹,Shi Xiao¹,Hu Jing¹,Li Li¹,Ding Zhou¹,Wang Ting⁴,Shen Jie¹,Yang Yang¹,Yu Lixia¹,Liu Baorui¹,Liu Chenchen⁵,Qian Xiaoping¹^ORCID

Affiliation:

1. The Comprehensive Cancer Center Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital Clinical Cancer Institute of Nanjing University Nanjing China

2. Department of Pulmonary Medicine Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

3. Department of Respiratory and Critical Care Medicine Affiliated Hospital of Nantong University Nantong China

4. Department of Pathology Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital Nanjing China

5. Department of Gastric Surgery Fudan University Shanghai Cancer Center Shanghai China

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1347

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Colorectal cancer

3. Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses

4. Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and Hopes

5. PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLAM family-mediated crosstalk between tumor and immune cells in the tumor microenvironment: a promising biomarker and a potential therapeutic target for immune checkpoint therapies;Clinical and Translational Oncology;2024-08-30

2. Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma;Oncology Letters;2024-06-03

3. In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis;International Journal of Molecular Sciences;2024-03-16

4. Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors;Frontiers in Immunology;2024-02-27

5. DeepRisk network: an AI-based tool for digital pathology signature and treatment responsiveness of gastric cancer using whole-slide images;Journal of Translational Medicine;2024-02-19